Inspira Technologies (IINN) entered into a strategic collaboration with Westchester Medical Center in Valhalla, New York. Westchester Medical Center, the flagship hospital in the Westchester Medical Center Health Network, will evaluate the performance and effectiveness of the new FDA cleared INSPIRA ART100 systems in various real-world clinical scenarios, exposing Inspira’s products and technologies to leading physicians and medical institutions. The strategic collaboration allows for Westchester Medical Center, a premier provider of advanced medical care, and Inspira Technologies to advance critical patient care with the deployment of Inspira’s proprietary INSPIRA ART100 systems. The parties have entered the strategic collaboration with the intention to mutually explore a long-term collaboration towards the future deployment of Inspira’s next-generation flagship technology, its INSPIRA ART system, which is currently in development and which is being designed to treat acute respiratory failure by elevating declining oxygen saturation levels in minutes without mechanical ventilators.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IINN: